Ureidopenicillin

Group of chemical compounds
Azlocillin
Piperacillin
Mezlocillin

The ureidopenicillins are a group of penicillins which are active against Pseudomonas aeruginosa.[citation needed]

There are three ureidopenicillins in clinical use:[1]

  • Azlocillin
  • Piperacillin
  • Mezlocillin

They are mostly ampicillin derivatives in which the amino acid side chain has been converted to a variety of cyclic ureas. It is speculated that the added side chain mimics a longer segment of the peptidoglycan chain, more than ampicillin, and thus would bind more easily to the penicillin-binding proteins. Ureidopenicillins are not resistant to beta-lactamases.[citation needed]

They are used parenterally, and are particularly indicated in infections caused by Gram-negative bacteria.[citation needed]

References

  1. ^ "Mayo Clinic Proceedings". Archived from the original on 2020-05-26. Retrieved 2008-12-26.
  • v
  • t
  • e
  • v
  • t
  • e
Antibacterials active on the cell wall and envelope (J01C-J01D)
Beta-lactams
(inhibit synthesis
of peptidoglycan
layer of bacterial
cell wall by binding
to and inhibiting
PBPs, a group of
D-alanyl-D-alanine
transpeptidases)
Penicillins (Penams)
Narrow
spectrum
β-lactamase sensitive
(1st generation)
β-lactamase resistant
(2nd generation)
Extended
spectrum
Aminopenicillins (3rd generation)
Carboxypenicillins (4th generation)
Ureidopenicillins (4th generation)
Other
Carbapenems / Penems
Cephems
Cephalosporins
Cephamycins
Carbacephems
1st generation
2nd generation
3rd generation
4th generation
5th generation
Siderophore
Veterinary
Monobactams
β-lactamase inhibitors
Combinations
Polypeptides
Glycopeptides
Lipoglycopeptides
Lipopeptides
Polymyxins
Other
  • Inhibits PG elongation and crosslinking: Ramoplanin§
Intracellular
Other